skip to Main Content
Interview With Dr Alessandro Carugo, Head Of Oncology At IRBM, On How We Are Reshaping Rare Cancer Drug Discovery In This Month’s Drug Discovery World
Image taken from original article on

Interview with Dr Alessandro Carugo, Head of Oncology at IRBM, on how we are reshaping rare cancer drug discovery in this month’s Drug Discovery World

Alessandro explains why building expert alliances as well as unique and ambitious drug discovery strategies across multiple drug modalities; from small molecules, peptides and monoclonal antibodies, is key to address unmet needs in oncology therapeutics.

Back To Top